Answers are grounded in this paper and cite their sources.
This editorial highlights findings that a polymorphism in the HO-1 gene promoter is associated with hypertension in Japanese women, suggesting a gender-specific role for the haeme oxygenase system in blood pressure regulation.
The elucidation of the human genome has opened up exciting opportunities for the exploration of genes impacting upon every aspect of cell, organ and system function, and their distinctive roles in males and females. It has led the way forward in allowing questions to be asked about the contribution of specific genes in the development of pathophysiological and disease states. In terms of hypertension research, the first forays utilizing the knowledge of the genome have been performed in association studies where attempts have been made, with varying degrees of success, to identify those genes that are abnormally expressed in hypertensive patients. Such association studies depend upon the availability of a solid population of subjects and patients from whom DNA material can be assessed, which represents a major problem. However, over recent years, a series of significant publications have appeared, originating from the National Cardiovascular Centre in Osaka, Japan, investigating hypertensive and associated diseases that may be linked to polymorphisms of selected genes. The material used in these studies was drawn from individuals randomly selected from the population of Suita, which is the second largest urban area in Japan and is encompassed within the Osaka metropolis. The Suita study comprises a cohort of some 14 200 men and women, aged 30–79 years, who were drawn from the municipal register, and who are invited to the Cardiovascular Centre every 2 years [1]. Leukocyte DNA was collected from all subjects attending between May 1996 and February 1998. The basic group of subjects therefore represents a homogeneous Japanese population in terms of lifestyle, diet and environmental factors. The first genetic investigations with this population base were performed by Iwai and coworkers in 2001 [2], in which they reported polymorphisms within the promoter regions of the gene encoding for the γ-subunit of the amiloride-sensitive epithelial cell sodium channel. The level of expression of this channel is likely to impact on the degree of fluid retention, and hence blood pressure. They were able to demonstrate that there was a significant relationship or association between one polymorphism and the level of blood pressure. This finding was supported further by the demonstration of a differential stimulation of the gene by the different alleles following an in-vitro transient transfection of epithelial cells. In developing this approach, their second study focused on the SA gene [3], which is expressed in the proximal tubules and hepatocytes. Importantly, expression of this gene is much higher in the kidneys of the rat model of hypertension, the spontaneously hypertensive rat [4,5], which suggests that it has an impact on tubular fluid reabsorption, and hence blood pressure. With this in mind, Iwai and coworkers investigated whether a differential rate of SA gene expression might be associated with hypertension. Their findings revealed that the polymorphisms with the introns of the SA gene were associated more with body mass index, hypertriglyceridaemia and waist-to-hip ratio rather than directly with blood pressure. These observations refocus attention on the exact role of the SA gene and raise the question of whether its function may be more at the level of the liver than the kidney. In this issue of the journal, Iwai et al. [6] develop this theme further but focus on the role of genes of the haeme-oxygenase system. This system comprises enzymes which break down the haeme residue giving rise to bile pigments, ferritin and the diffusible gas carbon monoxide (CO) which is the active constituent of the system. Two isoforms of haeme-oxygenase (HO) have been identified, HO-1 which is inducible, and HO-2 which is constitutively active [7]. The system is expressed to varying degrees within different tissues of the body, but within the cardiovascular system HO-2 has been found to be expressed in both endothelial and vascular smooth muscle cells [8]. Perhaps of greater significance is that oxidative stress in the rat kidney has been reported to increase HO-1 mRNA and protein expression within the cardiovascular system [9,10]. It is now recognized that CO activates soluble guanylate cyclase which causes relaxation of vascular smooth muscle cells and thereby has the potential of regulating vascular tone. Clearly, the HO system parallels the nitric oxide (NO) generating system and there is evidence that the two systems may interact competitively to activate guanylate cyclase [11]. However, the role of haeme oxygenase system and CO in the regulation of vascular tone remains to be determined. In their report, Iwai et al. [6] utilized a large number of subjects, some 1998 male and female individuals taken from the Suita study [1], and evaluated the genomic DNA in the region of HO-1. Their analysis revealed that there was a polymorphism in the promoter region of the HO-1 gene with two major alleles becoming apparent, the A(-413)-(GT)30 and T(-413)-(GT)23. They went on to utilize a luciferase reporter system transfected into bovine aortic endothelial cells and showed that the activity of the A(−413)-(GT)30 allele was some eight-fold higher than that of the T(-413)-(GT)23 allele. Consequently, they undertook an association study to determine whether any relationships existed between any variables measured in the subjects. This approach revealed that there was a significant association between the frequency of hypertensive subjects plus patients on antihypertensive therapy, and the presence of the A(413)-(GT)30 allele in the female population but not in the male population. This might be considered a somewhat surprising and unexpected observation for a number of reasons. First, HO-1 is the inducible form of the enzyme and may not necessarily be active in conditions of hypertension. Moreover, the question arises as to the level of activity of HO-2, the constitutive isoform. Although Iwai et al. [6] cite reports and provide arguments to support their view that CO generation is probably raised in these individuals such that it interferes with the ability of NO to modulate vascular tone, actual data to support this view are lacking. Nonetheless, it does point the way for further investigations to clarify this problem. A second intriguing point concerns the role of oestrogens in this system. The authors argue that oestogen does have an impact on vascular tone which is partly mediated by NO [12]. They suggest that CO generation by HO-1 may attenuate the generation of NO. The problem that arises is that, in their population of females, most must be post-menopausal and, consequently, plasma oestrogens may be low. However, as acknowledged by the authors in their article, at this age, adaptive vascular changes consequent to the chronically elevated blood pressure may be irreversible at this post-menopausal stage. In spite of all the issues that may follow and arise from their report, Iwai et al. [6] have generated very stimulating findings. These observations will now direct further attention into the role of the haeme oxygenase system, how it interacts with other vasodilator systems, and how the differences in alleles actually change the levels of HO-1 expression in the tissues of the body, and whether this is reflected in CO levels. The other important issue concerns gender and the impact of the different sex hormones on these systems.
No takes yet. Share an insight, caveat, or question.
Edward J. Johns (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: